SESSION ONE: WHAT’S NEW?

This session is of the following presentations:

Opening remarks
Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust</em?

Delinkage 1 year on
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement – North-East & Yorkshire, UK and immediate Past President, BSAC

SMASH study
Dr Ioannis Baltas, ST3 Infectious Diseases & Microbiology, University College London Hospitals NHS Foundation Trust & NIHR Academic Clinical Fellow in Infectious Diseases & Microbiology

Q&A

SESSION TWO: ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) – THE PRESENT AND THE FUTURE

This session is of the following presentations:

EUCAST update
Professor Alasdair MacGowan, Consultant in Infection, North Bristol NHS Trust & Professor of Antimicrobial Therapeutics, University of Bristol

Interpreting AST for paediatric patients
Dr Malte Kohns, University Children’s Hospital Basel

BSAC strategy and support for UK clinicians
Dr Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust

Q&A

SESSION THREE: CLINICAL CASES

This session is of the following presentations:

Unravelling the Phylogenetic History of Klebsiella pneumoniae Strains from Portugal: Insights on National And International Dissemination events
Dr Rita Elias, PhD student, iMed.ULisboa – Instituto de Investigação do Medicamento Faculdade de Farmácia da Universidade de Lisboa, Portugal

Prevalence and antibiotic profile of carbapenem resistant gram negative pathogens isolated from ventilator associated pneumonia patients in tertiary hospitals in Pakistan
Dr Zeb Hussain, PhD Student, University of Karachi

In vitro efficacy of novel therapeutic options for infections caused by carbapenemase-producing organisms
Dr Saied Ali, Microbiology Specialist Registrar, St Vincent’s University Hospital

Rational Antibiotic Escalation In Gram Negative Infections Applied to Specific Patient Groups
Dr Philip Williams, UKHSA & UHBW NHS Trust

SESSION SIX: REVIEW & ANALYSIS – IMPORTED AND EMERGING INFECTIONS

This session is of the following presentations:

Harnessing population-wide microbiology data for AMR surveillance and innovation
Dr Nick Daneman, Professor of Medicine, University of Toronto and Infection Prevention Physician, Public Health Ontario & Dr Kevin Brown, Infectious disease epidemiologist & health services researcher, Public Health Ontario & University of Toronto

Multidrug-resistant Gram-negative bacterial infections in war victims
Major Scott Pallett, ST5 Microbiology & Infectious Diseases Defence Medical Services, Frimley Park Hospital

Improving infection management – the MSF Mini-Lab in a LMIC setting
Professor Dimitri Van der Linden, Paediatric Infectious Diseases Consultant, Cliniques universitaires Saint-Luc (UCLouvain) – View Bio
Marjan Peeters, Médecins Sans Frontières (MSF)

Q&A

SESSION SEVEN: DEBATE – SHOULD ALL NEONATES IN WHOM TREATMENT WITH AMINOGLYCOSIDE ANTIBIOTICS IS BEING CONSIDERED, HAVE GENETIC TESTING FOR THE A1555G MUTATION?

This session is of the following presentations:

Scene setting
Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital

Pros
Professor Bill Newman, Chair of Translational Genomic Medicine & Consultant in Clinical Genetics, University of Manchester & Manchester University NHS Foundation Trust

Cons
Mr Stephen Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster Hospital NHS Foundation Trust

Discussion

SESSION EIGHT: INVITED LECTURE

This session is of the following presentations:

Why is the clinical treatment of Stenotrophomonas maltophilia still so challenging?
Dr Maria Mojica, Senior Instructor, Department of Molecular Biology & Microbiology, Case Western Reserve University, USA

Q&A

SESSION NINE: THE REAL WORLD IMPACT OF DATA – CONTROLLING AN OUTBREAK

This session is of the following presentations:

Detection and control of water-borne infection in augmented care units – are we doing enough?
Dr Jessica Martin, Clinical Microbiologist & Medical Lead for IPC and AMR, Leeds Teaching Hospitals Trust

To Screen or Not to Screen for Gram-negatives in Infection Control
Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust

Q&A